Frequency of Hypodontia After Chemotherapy in Childhood Cancer Survivors Study

Hypodontia Clinical Trial

Official title:

Frequency of Hypodontia After Chemotherapy in Childhood Cancer Survivors: A Cross Sectional Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03445026
• Other study ID #: CEBD-CU-2018-02-20
• Status: Recruiting
• Phase: N/A
• First received: February 20, 2018
• Last updated: February 23, 2018
• Start date: January 1, 2018
• Est. completion date: January 2019

Study information

• Verified date: February 2018
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to provide information on the frequency of hypodontia in children cancer survivors receiving chemotherapy before 4 years of age.Patients who met the eligibility criteria will be given a structured questionnaire to fill followed by a radiographic examination (dental panorama) for confirmation and standardization of the results.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 144
• Est. completion date: January 2019
• Est. primary completion date: December 2018
• Gender: All
• Age group: 6 Years and older

Eligibility

Inclusion Criteria:

• Aged 4 years or less when they first started their antineoplastic chemotherapy

• Both genders

• Able to cooperate

Exclusion Criteria:

• Children with known family history of hypodontia

• Children with any associated developmental anomalies (eg, ectodermal dysplasia, cleft lip or palate and Down syndrome)

• Children who received radiotherapy

• Children with previous loss of teeth due to trauma, caries, periodontal disease or extraction 5- Children who received bone marrow transplantation 6-Parents/patients unwilling to give informed consent

Related Conditions & MeSH terms

• Anodontia
• Hypodontia

Intervention

Diagnostic Test:
• dental panorama
radiographic examination

Locations

Country	Name	City	State
Egypt	Cairo university	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hypodontia	missing not formed teeth	1 year